Azithromycin for bronchiolitis by S Kanazawa 2024 Cited by 13They investigated the effect of azithromycin on bronchiolitis obliterans syndrome after lung transplantation. Because they administered azithromycin for Azithromycin for bronchiolitis Back To Search Results Editor: Contributor Profile University of Medicine & Health Sciences Niles, ILDisclosureOmar Iqbal, MD, has no relevant financial relationships with ineligible companies.">Omar A. Iqbal Updated: 11/9/2024 11:25:01 PM Indications Azithromycin is a broad-spectrum macrolide antimicrobial and one of the most frequently prescribed antimicrobial drugs in the United States. Azithromycin is an erythromycin derivative with greatly enhanced activity against gram-negative bacteria (including Enterobacteriaceae) that also provides coverage against many gram-positive organisms.[1][2] As an inhibitor of bacterial protein synthesis, azithromycin is effective against many "atypical" bacteria such as chlamydiae (eg, Chlamydia trachomatis and Chlamydophila psittaci), legionella (eg, Legionella pneumophila), mycoplasma (eg, Mycoplasma pneumoniae), and mycobacteria (eg, Mycobacterium avium).[3]FDA-Approved IndicationsCommunity-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis [4] Other upper respiratory infectious processes, including acute otitis media and acute exacerbation of chronic obstructive pulmonary disease (COPD) [5]Pharyngitis caused by Streptococcus pyogenes (as an alternative to a β-lactam agent)Skin infection due to S pyogenes, Streptococcus agalactiae, or Staphylococcus aureus M avium complex (MAC) infection treatment and prophylaxis for patients with advanced AIDSSexually transmitted infections, including chlamydia, gonococcal disease, chancroid (Haemophilus ducreyi), and Mycoplasma genitalium [6][7][8][9][10]Urethritis and cervicitis caused by C trachomatis or Neisseria gonorrhoeae. However, the CDC guidelines recommended azithromycin only in combination with gentamicin for uncomplicated gonococcal infections of the cervix or urethra, particularly for patients with a cephalosporin allergy.[11]Off-Label UsesSalmonella typhi infection (enteric fever) [12]Long-term prophylaxis for bronchiolitis obliterans (BO) in patients who have undergone lung transplantation [13]One study examined whether adding azithromycin to standard therapy could induce remission in patients with persistent uncontrolled asthma compared to placebo. Data from 335 participants over 12 months included increased rates of clinical remission and remission with lung function criteria, with some achieving complete remission. Factors such as better asthma-related quality of life predicted clinical remission. These findings suggest that azithromycin may help achieve asthma remission, highlighting its therapeutic potential. However, antimicrobial resistance should be considered.[14]A systematic review and meta-analysis suggest that azithromycin may reduce hospitalization duration in children with acute bronchiolitis who are younger than 2 years, but it does not prevent the recurrence of wheezing. Further Azithromycin for bronchiolitis Macrolide antibiotics such as azithromycin have been used for lower respiratory infections and pneumonia, as well as asthma, bronchiolitis, and COPD. Azithromycin for bronchiolitis Effect of Azithromycin on Lung Function and Pulmonary Exacerbations in Children with Post-infectious Bronchiolitis Obliterans. Azithromycin for bronchiolitis Acute Cough, Bronchitis (Adults) Bronchiolitis in Children Acute Cough in Azithromycin Prophylaxis in Adults with Respiratory Disease. Azithromycin for bronchiolitis Azithromycin to Prevent Recurrent Wheeze Following Severe Respiratory Syncytial Virus Bronchiolitis. azithromycin (10 mg/kg daily for 7 Azithromycin for bronchiolitis bronchitis/bronchiolitis, who were dispensed an antibiotic medication Clindamycin. Lincomycin. Macrolides. Azithromycin. Page 2. Clarithromycin. Azithromycin for bronchiolitis Marostica PJ. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial. The Journal of pediatrics. 2012 Dec:161(6):1104-8. doi: 10.1016/j.jpeds.2012.05.053. Epub 2012 Jun 28 [PubMed PMID: 22748516] Level 1 (high-level) evidence [27] Echeverría-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, De-Antonio Cuscó M, Ferrández O, Horcajada JP, Grau S. Azithromycin in the treatment of COVID-19: a review. Expert review of anti-infective therapy. 2021 Feb:19(2):147-163. doi: 10.1080/14787210.2020.1813024. Epub 2020 Oct 6 [PubMed PMID: 32853038] [28] Goldman RC, Fesik SW, Doran CC. Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrobial agents and chemotherapy. 1990 Mar:34(3):426-31 [PubMed PMID: 2159256] [29] Jelić D, Antolović R. From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials. Antibiotics (Basel, Switzerland). 2016 Sep 1:5(3):. doi: 10.3390/antibiotics5030029. Epub 2016 Sep 1 [PubMed PMID: 27598215] [30] Neu HC. Clinical microbiology of azithromycin. The American journal of medicine. 1991 Sep 12:91(3A):12S-18S [PubMed PMID: 1656736] Level 3 (low-level) evidence [31] Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. The Journal of biological chemistry. 2007 Jan 26:282(4):2494-504 [PubMed PMID: 17110371] Level 3 (low-level) evidence [32] Biddau M, Sheiner L. Targeting the apicoplast in malaria. Biochemical Society transactions. 2019 Aug 30:47(4):973-983. doi: 10.1042/BST20170563. Epub 2019 Aug 5 [PubMed PMID: 31383817] [33] Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. American journal of respiratory and critical care medicine. 2006 Sep 1:174(5):566-70 [PubMed PMID: 16741151] [34] Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells. 2024 Jan 16:13(2):. doi: 10.3390/cells13020166. Epub 2024 Jan 16 [PubMed PMID: 38247856] [35] Menzel M, Akbarshahi H, Bjermer L, Uller L. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients. Scientific reports. 2016 Jun 28:6():28698. doi: 10.1038/srep28698. Effect of Azithromycin on Lung Function and Pulmonary Exacerbations in Children with Post-infectious Bronchiolitis Obliterans. Azithromycin for bronchiolitis by P Tamilarasan 2024Effect of azithromycin administration in cases of acute bronchiolitis – A systematic review and meta-analysis. Azithromycin for bronchiolitis Semantic Scholar extracted view of Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a Azithromycin for bronchiolitis Macrolide antibiotics such as azithromycin have been used for lower respiratory infections and pneumonia, as well as asthma, bronchiolitis, and COPD. Azithromycin for bronchiolitis Acute exacerbation of chronic bronchitis. Community-acquired pneumonia. Prevention Azithromycin in bronchiolitis obliterans complicating bone marrow Azithromycin for bronchiolitis A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. European Respiratory Journal 2024; 32 (4):832‐43. [MEDLINE: ] [Google Scholar] Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Azithromycin for bronchiolitis A treatment for bladder cancer. While product labeling advises suspending BCG therapy during antibiotic treatment due to potential interference with clinical response, antibiotics may still be necessary during this interval. A recent study of 126 patients found no significant impact of antibiotics on recurrence-free or progression-free survival during BCG induction. Prolonged antibiotic treatment did extend the duration of BCG therapy, but overall, antibiotics did not adversely affect oncological outcomes or adverse effects; a thorough risk-benefit evaluation is required.[59] Contraindications Azithromycin is contraindicated for patients with a history of severe hypersensitivity (eg, anaphylaxis or SJS) to azithromycin or another macrolide antimicrobial. Azithromycin is also contraindicated for patients with a history of cholestatic jaundice or hepatic dysfunction related to prior use of the drug.Warning and PrecautionsAzithromycin effectively preserves FEV and ameliorates bronchiolitis obliterans (BO) with no effect on overall survival in lung transplant patients; however, a study comparing azithromycin with placebo for the prevention of BO in hematopoietic stem cell transplant (HSCT) recipients demonstrated decreased BO-free and overall survival with azithromycin.[60] Hence, long-term azithromycin prophylaxis in HSCT recipients is inadvisable.Clinicians should be cautious regarding the concomitant use of azithromycin and other medications that prolong the QTc interval, such as antipsychotics.According to the KIDs list (Key Potentially Inappropriate Drugs in Pediatrics), azithromycin should be avoided in neonates due to the risk of hypertrophic pyloric stenosis.[61] Monitoring Most courses of treatment with azithromycin are short, and adverse effects requiring therapy adjustment or discontinuation of azithromycin are rare.[44] Azithromycin should be immediately discontinued if signs of hepatotoxicity develop (eg, jaundice or elevated transaminases). For patients receiving long-term azithromycin prophylaxis (eg, AIDS patients for MAC prophylaxis or lung transplant recipients for BO prophylaxis), many patients experience gastrointestinal adverse effects, especially at higher doses (ie, 600 or 1200 mg). Reducing the dose or twice-daily dosing may be considered for these patients.[62][63] Toxicity Signs and Symptoms of OverdoseAzithromycin, like other macrolides, is associated with QTc prolongation. Azithromycin administration can result in potentially lethal arrhythmias such as torsades de pointes. This is particularly true for patients with a history of QTc interval perturbation, cardiac arrhythmia, or concomitant use of Azithromycin for bronchiolitis Azithromycin: Belongs to the class of antibiotics. Used in the treatment of Azithromycin should not be given long-term to prevent bronchiolitis Azithromycin for bronchiolitis Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis Azithromycin for bronchiolitis azithromycin as an indication for long-term prophylaxis for exacerbations of. COPD, asthma, bronchiectasis, and treatment of bronchiolitis obliterans Azithromycin for bronchiolitis azithromycin compared with placebo; Azithromycin is not indicated for prophylaxis of bronchiolitis obliterans syndrome (BOS) in patients undergoing HSCT and Azithromycin for bronchiolitis by S Kanazawa 2024 Cited by 13They investigated the effect of azithromycin on bronchiolitis obliterans syndrome after lung transplantation. Because they administered azithromycin for Azithromycin for bronchiolitis Kuitunen I. Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis. Pediatric research. 2024 May:95(6):1441-1447. doi: 10.1038/s41390-023-02953-z. Epub 2023 Dec 8 [PubMed PMID: 38066246] Level 1 (high-level) evidence [16] Southern KW, Solis-Moya A, Kurz D, Smith S. Macrolide antibiotics (including azithromycin) for cystic fibrosis. The Cochrane database of systematic reviews. 2024 Feb 27:2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5. Epub 2024 Feb 27 [PubMed PMID: 38411248] Level 1 (high-level) evidence [17] Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. American journal of respiratory and critical care medicine. 2013 Apr 1:187(7):680-9 [PubMed PMID: 23540878] Level 1 (high-level) evidence [18] Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. The New England journal of medicine. 2000 Nov 16:343(20):1454-8 [PubMed PMID: 11078770] Level 3 (low-level) evidence [19] Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, Patel K, Mohapatra MK, Lakhani J, Benner R, Lele C, Patki K. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. The Journal of infectious diseases. 2005 May 15:191(10):1582-8 [PubMed PMID: 15838784] Level 1 (high-level) evidence [20] Shiojiri D, Kinai E, Teruya K, Kikuchi Y, Oka S. Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis. Emerging infectious diseases. 2019 Apr:25(4):841-843. doi: 10.3201/eid2504.181689. Epub [PubMed PMID: 30882331] [21] . Corrigendum to: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Jul 1:73(1):172-173. doi: 10.1093/cid/ciab275. Epub [PubMed PMID: 33960362] Level 1 (high-level) evidence [22] Krause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lantos PM, Lavergne V, Meissner HC, Osani MC, Rips JG, Sood SK, Vannier E, Impact Azithromycin may reduce hospitalization time in acute bronchiolitis and wheezing episodes among children aged less than two. Azithromycin Azithromycin for bronchiolitis Acute exacerbation of chronic bronchitis. Community-acquired pneumonia. Prevention Azithromycin in bronchiolitis obliterans complicating bone marrow Azithromycin for bronchiolitis azithromycin as an indication for long-term prophylaxis for exacerbations of. COPD, asthma, bronchiectasis, and treatment of bronchiolitis obliterans Azithromycin for bronchiolitis Prophylaxis or treatment of respiratory infection in children with bronchiectasis and/or bronchiolitis obliterans. Azithromycin has anti-inflammatory Azithromycin for bronchiolitis Additionally, she exhibited lack-of-efficacy with prednisone and azithromycin for follicular bronchiolitis [routes not stated; not all dosages Azithromycin for bronchiolitis In another disease with features of bronchiolitis, bronchiolitis obliterans after lung transplantation, azithromycin showed an ability to slow down the Azithromycin for bronchiolitis Kuitunen I. Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis. Pediatric research. 2024 May:95(6):1441-1447. doi: 10.1038/s41390-023-02953-z. Epub 2023 Dec 8 [PubMed PMID: 38066246] Level 1 (high-level) evidence [16] Southern KW, Solis-Moya A, Kurz D, Smith S. Macrolide antibiotics (including azithromycin) for cystic fibrosis. The Cochrane database of systematic reviews. 2024 Feb 27:2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5. Epub 2024 Feb 27 [PubMed PMID: 38411248] Level 1 (high-level) evidence [17] Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. American journal of respiratory and critical care medicine. 2013 Apr 1:187(7):680-9 [PubMed PMID: 23540878] Level 1 (high-level) evidence [18] Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. The New England journal of medicine. 2000 Nov 16:343(20):1454-8 [PubMed PMID: 11078770] Level 3 (low-level) evidence [19] Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, Patel K, Mohapatra MK, Lakhani J, Benner R, Lele C, Patki K. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. The Journal of infectious diseases. 2005 May 15:191(10):1582-8 [PubMed PMID: 15838784] Level 1 (high-level) evidence [20] Shiojiri D, Kinai E, Teruya K, Kikuchi Y, Oka S. Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis. Emerging infectious diseases. 2019 Apr:25(4):841-843. doi: 10.3201/eid2504.181689. Epub [PubMed PMID: 30882331] [21] . Corrigendum to: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Jul 1:73(1):172-173. doi: 10.1093/cid/ciab275. Epub [PubMed PMID: 33960362] Level 1 (high-level) evidence [22] Krause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lantos PM, Lavergne V, Meissner HC, Osani MC, Rips JG, Sood SK, Vannier E, Azithromycin for bronchiolitis Acute exacerbation of chronic bronchitis. Community-acquired pneumonia. Prevention Azithromycin in bronchiolitis obliterans complicating bone marrow Azithromycin for bronchiolitis hypersensitivity to drug or ingredient cholestatic jaundice hx, azithromycin-associated hepatic impairment hx, azithromycin-associated bronchiolitis Azithromycin for bronchiolitis Clindamycin Lincomycin. Macrolides. Azithromycin Clarithromycin bronchitis/bronchiolitis due to the viral origin of acute bronchitis/bronchiolitis. Azithromycin for bronchiolitis Effect of Azithromycin on Lung Function and Pulmonary Exacerbations in Children with Post-infectious Bronchiolitis Obliterans. Azithromycin for bronchiolitis kidney and bladder and exhibited anti-inflammatory and Azithromycin is mostly used to treat lung infection and viral bronchiolitis. Azithromycin for bronchiolitis Medically reviewed by Carmen Pope, BPharm. Last updated on May 16, 2024. How it worksUpsidesDownsidesBottom LineTipsResponse/effectivenessInteractions 1. How it works Propranolol is a medicine that may be used to treat certain heart conditions, reduce essential tremor, or prevent migraine. It works by blocking beta receptors. There are two types of beta receptors, beta-1 receptors (located in the heart) and beta-2 receptors (located in the bronchioles of the lungs and the arteries of skeletal muscle). Propranolol blocks beta-1 receptors in the heart which slows the heart rate and decreases how hard the heart has to work to pump blood around the body, decreasing blood pressure. Propranolol has a "nonselective" action. This means that it also blocks beta-2 receptors in the bronchioles, which can cause a narrowing of the bronchioles which may cause breathing difficulties in people with pre-existing lung disease. Propranolol also has a membrane-stabilizing effect at higher dosages which can affect the electrical impulses of the heart, although is not thought to contribute much to its antiarrhythmic properties.Experts are not sure how propranolol works to prevent migraines or tremors. Propranolol belongs to a class of medicines known as beta-adrenergic blockers or beta-blockers. 2. Upsides May be used to treat high blood pressure (hypertension), either alone or in combination with thiazide diuretics or other medicines for hypertension.May improve the symptoms of angina and increase a person with angina's capacity to exercise.May be used in the prevention of migraine headaches. May improve symptoms of hypertrophic subaortic stenosis; however, will not change the course of the disease.Approved for the treatment of essential tremor (ET). Reduces tremor amplitude but not frequency; complete suppression of tremor is rare. Appears to work best for high-amplitude, low-frequency ET.Generic propranolol is available. 3. Downsides If you are between the ages of 18 and 60, take no other medication A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. European Respiratory Journal 2024; 32 (4):832‐43. [MEDLINE: ] [Google Scholar] Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Azithromycin for bronchiolitis Macrolide antibiotics such as azithromycin have been used for lower respiratory infections and pneumonia, as well as asthma, bronchiolitis, and COPD. Azithromycin for bronchiolitis Health care professionals should not prescribe long-term azithromycin for prophylaxis of bronchiolitis obliterans syndrome to patients who Azithromycin for bronchiolitis Clindamycin Lincomycin. Macrolides. Azithromycin Clarithromycin bronchitis/bronchiolitis due to the viral origin of acute bronchitis/bronchiolitis. Azithromycin for bronchiolitis urinary tract infections in vitro. The efficacy of a Azithromycin is mostly used to treat lung infection and viral bronchiolitis. Azithromycin for bronchiolitis by M Khalid 2024Role of Azithromycin in Bronchiolitis. Obliterans / Obliterative Bronchiolitis in. Post-Bone Marrow Transplant (BMT). Patient. M Khalid, MBBS Azithromycin for bronchiolitis Medically reviewed by Carmen Pope, BPharm. Last updated on May 16, 2024. How it worksUpsidesDownsidesBottom LineTipsResponse/effectivenessInteractions 1. How it works Propranolol is a medicine that may be used to treat certain heart conditions, reduce essential tremor, or prevent migraine. It works by blocking beta receptors. There are two types of beta receptors, beta-1 receptors (located in the heart) and beta-2 receptors (located in the bronchioles of the lungs and the arteries of skeletal muscle). Propranolol blocks beta-1 receptors in the heart which slows the heart rate and decreases how hard the heart has to work to pump blood around the body, decreasing blood pressure. Propranolol has a "nonselective" action. This means that it also blocks beta-2 receptors in the bronchioles, which can cause a narrowing of the bronchioles which may cause breathing difficulties in people with pre-existing lung disease. Propranolol also has a membrane-stabilizing effect at higher dosages which can affect the electrical impulses of the heart, although is not thought to contribute much to its antiarrhythmic properties.Experts are not sure how propranolol works to prevent migraines or tremors. Propranolol belongs to a class of medicines known as beta-adrenergic blockers or beta-blockers. 2. Upsides May be used to treat high blood pressure (hypertension), either alone or in combination with thiazide diuretics or other medicines for hypertension.May improve the symptoms of angina and increase a person with angina's capacity to exercise.May be used in the prevention of migraine headaches. May improve symptoms of hypertrophic subaortic stenosis; however, will not change the course of the disease.Approved for the treatment of essential tremor (ET). Reduces tremor amplitude but not frequency; complete suppression of tremor is rare. Appears to work best for high-amplitude, low-frequency ET.Generic propranolol is available. 3. Downsides If you are between the ages of 18 and 60, take no other medication Azithromycin for bronchiolitis Health care professionals should not prescribe long-term azithromycin for prophylaxis of bronchiolitis obliterans syndrome to patients who Azithromycin for bronchiolitis Clindamycin Lincomycin. Macrolides. Azithromycin Clarithromycin bronchitis/bronchiolitis due to the viral origin of acute bronchitis/bronchiolitis. Azithromycin for bronchiolitis In another disease with features of bronchiolitis, bronchiolitis obliterans after lung transplantation, azithromycin showed an ability to slow down the progress Azithromycin for bronchiolitis Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients Was this helpful? Donate. If you found Azithromycin for bronchiolitis Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant Bronchiolitis Obliterans. Azithromycin for bronchiolitis Reuter, Suzanne; Moser, Chuanpit; Baack, Michelle (2014). "Respiratory Distress in the Newborn". Pediatrics in Review. 35 (10): 417–429. doi:10.1542/pir.35-10-417. ISSN 0191-9601. PMC 4533247. PMID 25274969.^ Jalota Sahota, Ruchi; Anjum, Fatima (2022), "Pulmonary Interstitial Emphysema", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32809319, archived from the original on 2023-12-26, retrieved 2022-05-14^ "Bronchiolitis: MedlinePlus Medical Encyclopedia". medlineplus.gov. Archived from the original on 2023-01-30. Retrieved 2022-05-14.^ Justice, Nathaniel A.; Le, Jacqueline K. (2022), "Bronchiolitis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722988, archived from the original on 2022-08-14, retrieved 2022-05-14^ Friedman, Jeremy N; Rieder, Michael J; Walton, Jennifer M (2014). "Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age". Paediatrics & Child Health. 19 (9): 485–491. doi:10.1093/pch/19.9.485. ISSN 1205-7088. PMC 4235450. PMID 25414585.^ "National Institutes of Health – common cold". Archived from the original on 2008-10-01. Retrieved 2008-05-07.^ Wier LM, Yu H, Owens PL, Washington R (May 2013). "Overview of Children in the Emergency Department, 2010". HCUP Statistical Brief (157). Agency for Healthcare Research and Quality. PMID 24006551. Archived from the original on 2013-12-03. Retrieved 2013-07-17.^ Witt WP, Wiess AJ, Elixhauser A (December 2014). "Overview of Hospital Stays for Children in the United States, 2012". HCUP Statistical Brief (186). Rockville, MD: Agency for Healthcare Research and Quality. PMID 25695124. Archived from the original on 2018-09-24. Retrieved 2015-04-06.^ "What is COPD?". British Lung Foundation. 7 September 2015. Archived from the original on 20 January 2022. Retrieved 16 May 2019.^ "Public Health Agency of Canada – Centre for Chronic Disease Prevention and Control Chronic Respiratory Diseases". Archived from the original on 2008-04-11. Retrieved 2008-05-06.^ Barrett ML, Smith MW, Elizhauser A, Honigman LS, Pines JM (December 2014). "Utilization of Intensive Care Services, 2011". HCUP Statistical Brief (185). Rockville, MD: Agency for Healthcare Research and Quality. PMID 25654157. Archived from the original on 2015-04-02. Retrieved 2015-04-06. Macrolide antibiotics such as azithromycin have been used for lower respiratory infections and pneumonia, as well as asthma, bronchiolitis, and COPD. Azithromycin for bronchiolitis In another disease with features of bronchiolitis, bronchiolitis obliterans after lung transplantation, azithromycin Azithromycin maintenance treatment Azithromycin for bronchiolitis Additionally, she exhibited lack-of-efficacy with prednisone and azithromycin for follicular bronchiolitis [routes not stated; not all dosages Azithromycin for bronchiolitis Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis Azithromycin for bronchiolitis urinary tract infections in vitro. The efficacy of a Azithromycin is mostly used to treat lung infection and viral bronchiolitis. Azithromycin for bronchiolitis
Maintenance Azithromycin Therapy for Bronchiolitis
Azithromycin for the Treatment of Obliterative Bronchiolitis